Progyny, Inc.(PGNY)Earnings, Financials & Key RatiosProgyny, Inc. (PGNY) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the company maintains a robust FCF margin of 12.1% in 2026Q1, the high PEG ratio of 6.55 suggests that the current valuation may not adequately price in the risks associated with decelerating revenue growth.
Progyny, Inc. (PGNY) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Progyny, Inc. (PGNY) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $0.29vs $0.26+13.3% | $329Mvs $326M+0.6% |
| Q1 2026 | Feb 26, 2026 | $0.15vs $0.15+2.0% | $318Mvs $307M+3.6% |
| Q4 2025 | Nov 6, 2025 | $0.45vs $0.39+15.4% | $313Mvs $314M-0.3% |
| Q3 2025 | Aug 7, 2025 | $0.48vs $0.44+9.1% | $333Mvs $299M+11.2% |
Recent stock market news and headlines for Progyny, Inc. (PGNY)
CFO Mark Livingston sold 8,275 shares for a transaction value of ~$211,000 on May 20, 2026. This represented 9.47% of Livingston's direct holdings, reducing his direct position to 79,063 shares.
Key metrics vs top competitors for Progyny, Inc. (PGNY)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $30.78 | $2.41B | 47.35 | 10.4% | 4.54% | 12.48% | — | |
| $36.17 | $7.94B | 70.92 | 59% | -0.56% | -2.48% | — | |
| $10.90 | $4.23B | 545.00 | 13.85% | 1.55% | 1.56% | — | |
| $3.03 | $1.05B | 35.52 | 0.57% | 3.74% | 4.75% | — | |
| $104.33 | $133.12B | 75.06 | 7.85% | 0.72% | 3.86% | — | |
| $286.62 | $75.57B | 12.93 | 11.26% | 2.26% | 15.08% | — |
Progyny, Inc. (PGNY) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Progyny, Inc. (PGNY) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 7, 2026·SEC
Mar 13, 2026·SEC
Feb 26, 2026·SEC
Get notified when PGNY posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Progyny, Inc. (PGNY) stock FAQ — growth, dividends, profitability & financials explained
Progyny, Inc. (PGNY) reported $1.29B in revenue for fiscal year 2025. This represents a 2562% increase from $48.6M in 2017.
Progyny, Inc. (PGNY) grew revenue by 10.4% over the past year. This is steady growth.
Yes, Progyny, Inc. (PGNY) is profitable, generating $67.7M in net income for fiscal year 2025 (4.5% net margin).
Progyny, Inc. (PGNY) has a return on equity (ROE) of 12.5%. This is reasonable for most industries.
Progyny, Inc. (PGNY) generated $181.3M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
